85 related articles for article (PubMed ID: 16292724)
1. Ziprasidone overdose: cardiac safety.
Insa Gómez FJ; Gutiérrez Casares JR
Actas Esp Psiquiatr; 2005; 33(6):398-400. PubMed ID: 16292724
[TBL] [Abstract][Full Text] [Related]
2. Ziprasidone overdose: cases recorded in the database of Pfizer-Spain and literature review.
Gómez-Criado MS; Bernardo M; Florez Td; Gutiérrez JR; Gandía R; Ayani I
Pharmacotherapy; 2005 Nov; 25(11):1660-5. PubMed ID: 16232029
[TBL] [Abstract][Full Text] [Related]
3. Ziprasidone and the QTc interval: pharmacokinetic and pharmacodynamic considerations.
Kelly DL; Love RC
Psychopharmacol Bull; 2001; 35(4):66-79. PubMed ID: 12397857
[TBL] [Abstract][Full Text] [Related]
4. [Ziprasidone. A new second-generation antipsychotic agent].
Lublin HK
Ugeskr Laeger; 2004 Mar; 166(14):1334-9. PubMed ID: 15101124
[No Abstract] [Full Text] [Related]
5. Multi-drug overdose risperidone, ziprasidone, valproate, trihexyphenidyl, and clonazepam.
Rajkumar AP; Jebaraj P; Tharyan P
J Assoc Physicians India; 2007 Feb; 55():146-8. PubMed ID: 17571746
[TBL] [Abstract][Full Text] [Related]
6. Ziprasidone security in overdose: one case report.
Rodriguez Martinez A; Castaño Asins J
Actas Esp Psiquiatr; 2007; 35(4):282-3. PubMed ID: 17717866
[No Abstract] [Full Text] [Related]
7. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
Ozen ME; Yumru M; Savas HA; Cansel N; Herken H
World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349
[TBL] [Abstract][Full Text] [Related]
8. Prospective observational multi-poison center study of ziprasidone exposures.
Klein-Schwartz W; Lofton AL; Benson BE; Spiller HA; Crouch BI
Clin Toxicol (Phila); 2007; 45(7):782-6. PubMed ID: 17926152
[TBL] [Abstract][Full Text] [Related]
9. Ziprasidone, monoamine oxidase inhibitors, and the serotonin syndrome.
Rim CL; Gitlin MJ
J Clin Psychopharmacol; 2010 Aug; 30(4):470-1. PubMed ID: 20631570
[No Abstract] [Full Text] [Related]
10. Neuroleptic Malignant Syndrome with ziprasidone.
Murty RG; Mistry SG; Chacko RC
J Clin Psychopharmacol; 2002 Dec; 22(6):624-6. PubMed ID: 12454565
[No Abstract] [Full Text] [Related]
11. Inadvertent administration of intravenous ziprasidone leading to bradycardia and QT interval prolongation.
Bentley ML; Biscardi FH; Butcher C; Levitov A
Ann Pharmacother; 2008 Jun; 42(6):902-3. PubMed ID: 18477728
[No Abstract] [Full Text] [Related]
12. [Ziprasidone and dementia].
Aakhus E
Tidsskr Nor Laegeforen; 2004 Aug; 124(16):2155-6; author reply 2155-6. PubMed ID: 15334150
[No Abstract] [Full Text] [Related]
13. Pediatric ziprasidone overdose.
Fasano CJ; O'Malley GF; Lares C; Rowden AK
Pediatr Emerg Care; 2009 Apr; 25(4):258-9. PubMed ID: 19369840
[TBL] [Abstract][Full Text] [Related]
14. A case series of ziprasidone overdoses.
Bryant SM; Zilberstein J; Cumpston KL; Magdziarz DD; Costerisan DD
Vet Hum Toxicol; 2003 Mar; 45(2):81-2. PubMed ID: 12678292
[TBL] [Abstract][Full Text] [Related]
15. The highest intentional ziprasidone overdose was not fatal.
Prieto T; Benabarre A; Bernardo M
Acta Psychiatr Scand; 2005 Jul; 112(1):79-80; author reply 80. PubMed ID: 15952953
[No Abstract] [Full Text] [Related]
16. No significant QTc interval changes with high-dose ziprasidone: a case series.
Levy WO; Robichaux-Keene NR; Nunez C
J Psychiatr Pract; 2004 Jul; 10(4):227-32. PubMed ID: 15552544
[TBL] [Abstract][Full Text] [Related]
17. Metoprolol and diltiazem ameliorate ziprasidone-induced prolonged corrected QT interval in rats.
Erbas O; Yilmaz M
Toxicol Ind Health; 2015 Dec; 31(12):1152-7. PubMed ID: 23625911
[TBL] [Abstract][Full Text] [Related]
18. High-dose ziprasidone-induced acute dystonia.
Rosenfield PJ; Girgis RR; Gil R
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):546-7. PubMed ID: 17123682
[TBL] [Abstract][Full Text] [Related]
19. Probable association between ziprasidone and worsening hypertension.
Villanueva N; Markham-Abedi C; McNeely C; Diaz FJ; de Leon J
Pharmacotherapy; 2006 Sep; 26(9):1352-7. PubMed ID: 16945059
[TBL] [Abstract][Full Text] [Related]
20. Naturalistic study of intramuscular ziprasidone versus conventional agents in agitated elderly patients: retrospective findings from a psychiatric emergency service.
Kohen I; Preval H; Southard R; Francis A
Am J Geriatr Pharmacother; 2005 Dec; 3(4):240-5. PubMed ID: 16503319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
